References
- Scheuplein RJ. Mechanism of percutaneous absorption. L Routes of penetration and the influence of solubility. J Invest Dermatol. 1965; 45: 334–46.
- Scheuplein RJ. Mechanism of percutaneous absorption. II. Tran-sient diffusion and relative importance of various routes of skin penetration. J Invest Dermatol 1967; 48: 79–88.
- Scheuplein RJ. Percutaneous absorption after twenty-five years: "old wine in new wineskins." J Invest Dermatol 1976; 67: 31–8.
- Scheuplein RJ. Permeability of the skin: a review of major con-cepts and some new developments. J Invest Dermatol. 1976; 67: 672–6.
- Scheuplein RJ. Permeability of the skin. In: Lee DHK (ed). Hand-book of Physiology. 9: Reaction to Environmental Agents. Bethesda, MD: Physiology of Society, 1977; 299-322.
- Scheuplein RJ. Permeability of the skin: a review of major con-cepts. Gun Probl Dermatol. 1997-8; 7: 172-86.
- Scheuplein RJ. Blank 1H. Permeability of the skin. Physiol Rev. 1971; 51: 702–47.
- Scheuplein RJ, Blank IH. Mechanisms of percutaneous absorp-tion. IV. Penetration of non-electrolytes (alcohols) from aqueous solutions and from pure liquids. J Invest Dermatol. 1973; 60: 286–97.
- Scheuplein RJ, Ross LW. Mechanisms of percutaneous absorp-tion. V. Percutaneous absorption of solvent deposited solids. J In-vest Dermatol. 1974; 62: 353–60.
- Dutkiewicz B, Koficzalik J, Korwacki W. Skin absorption and per os administration of methanol in men. Int Arch Occup Environ Health. 1980; 47: 81–8.
- Baranowska B. Evaluation of the skin as absorption way for carbon disulphide. Int Arch Gewerbepath Gewerbehyg. 1965; 21: 362-8. [In German]
- Baranowska-Dutkiewicz B. Absorption of hexavalent chromium by skin in men. Arch Toxicol. 1981; 47: 47.
- Baranowska-Dutkiewicz B. Evaluation of the skin uptake of mer-curic chloride in man. J Appl Toxicol. 1982; 2: 223–5
- Baranowska-Dutkiewicz B. The absorption of industrial poisons through the skin in men [dissertation]. &lesion Medical Acad-emy, Katowice, Poland, 1981, [In Polish]
- Auton TR, Westhead DR, Woollen BH, Scott RC, Wilks MF. A physiologically based mathematical model of dermal absorption in man. Hum F,orp Toxicol. 1994; 13: 51–60.
- Kubota K, Maibach HI. A compartment model for percutaneous absorption: compatibility of lag time and steady-state flux with dif-fusion model. J Pharmacol Sci. 1992; 81: 863–5.
- Liang WO, Lin W. The effect of molecular volume and partition coefficient on percutaneous absorption. Yao Hsueh Pao Acta Pharrnaceutica Sinica. 1992; 27: 684–9. [In Chinese]
- Boman A. Percutaneous absorption of 3 organic solvents in the guinea pig. V. Effect of "accelerants." Contact Dermatitis. 1989; 21: 304–11.
- Walhberg JE, Skog E. The effect of dimethyl sulfoidde on the per-cutaneous absorption of mercuric chloride in the guinea pig. Acta Dermato-Venereol. 1967; 47: 209–15.
- Rouger A, Dupuis D, Lone C, Roguet R, Wester RC, Maibach HI. Re-gional variation in percutaneous absorption in man: measurement by the stripping method. Arch Dermatol Res. 1986; 278: 465–9.
- Guy RH, Maibach HI. Correction factors for determining body ex-posure from forearm percutaneous absorption data. J Appl Toxi-col. 1984; 4: 26–8.
- Boman A, Mellstrom G. Percutaneous absorption of 3 organic sol-vents in the guinea pig. III. Effect of barrier creams. Contact Der-matitis. 1989; 21: 134–40.
- Roskos KW, Maibach HI. Percutaneous absorption and age. Im-plications for therapy. Drugs and Aging. 1992; 2: 432–49.
- Rutter N. Percutaneous drug absorption in the newborn: hazards and uses. Clin Perinatol. 1987; 14: 911–30.
- Lotte C, Wester RC, Rougier A, Maibach HI. Racial differences in the in vivo percutaneous absorption of some organic compounds: a comparison between black, Caucasian and Asian subjects. Arch Dermatol Res. 1993; 284: 456–9.
- Skog E, Walberg JE. A comparative investigation of the percuta-neous absorption of metal compound in guinea pig by mean of the radioactive isotopes: ttCr, 58co, 65zn, 110mAg, 115mcd, 203Hg. Invest Dermatol. 1964; 43: 187–92.
- Wahlberg JE. Percutaneous absorption of sodium chromate (51Cr), cobaltous (58Co), and mercuric (283I-Ig) chlorides through excised human and guinea pig skin. Acta Dermato-Venereol. 1965; 45: 416–26.
- Stauber JL, Florence TM, Gulson B, Dale LS. Percutaneous ab-sorption of inorganic lead. Sci Total Environ. 1994; 145: 55–70.
- Hurs JB, Clarkson TW, Miles EF, Goldsmith LA. Percutaneous ab-sorption of mercury vapor by man. Arch Environ Health. 1989; 42: 120–7.
- Hostynek J, Hinz RS, Lorence CR, Price M, Guy RH. Metals and the skin. Crit Rev Toxicol. 1993; 23: 171–235.
- Wester RC, Maibach HI, Sedik L, Melendres J, Wade M. Percuta-neous absorption of PCBs from soil: in vivo rhesus monkey, in vitro human skin, and binding to powdered human stratum corneum. J Toxicol Environ Health. 1993; 39: 375–82.
- Dick D, Ng KM, Sander DN, Chu I. In vitro and in vivo percuta-neous absorption of 14C-chloroform in humans. Hum Exp Toxi-col. 1995; 14: 260–5.
- Ng KM, Chu I, Bronaugh RL, Franklin CA, Somers DA. Percuta-neous absorption and metabolism of pyrene, bazo [a] pyrene, and di (2-ethylhexyl) phthalate: comparison of in vitro and in vivo re-sults in the hairless guinea pig. Toxicol Appl Pharmacol. 1992; 115: 216–23.
- Yang JJ, Roy TA, Mackerer CR. Percutaneous absorption of benzo [a]pyrene in the rat: comparison of in vivo and in vitro re-sults. Toxicol Ind Health. 1986; 2: 409–16.
- Yang lb Roy TA, Mackerer CR. Percutaneous absorption of an-thracene in the rat: comparison of in vivo and in vitro results. Tox-icol Intl Health. 1986; 2: 79–84.
- Banks YB, Birnbaum LS. Absorption of 2,3,7,8-tetrachlo-rodibenzo-p-dioxin (TCDD) after low dose dermal exposure. Toxicol Appl Pharmacol. 1991; 107: 302–10.
- Boman A, Blute I, Ferstrom P, Calfors J, Rydhag L. Percutaneous absorption of 4 organic solvents in the guinea pig. II. Effect of sur-factants. Contact Dermatitis. 1989; 21: 92–104.
- Boman A, Walberg JE. Percutaneous absorption of 3 organic sol-vents in the guinea pig. I. Effect of physical and chemical injuries to the skin. Contact Dermatitis. 1989; 21: 36–45.
- Kolmodin-Hedman B, Borglund E, Werner Y. Percutaneous ab-sorption of DDT from a parasiticide used for treatment of scabies. Acta Dermatol Venereol. 1979; 59: 276–8.
- Purchase IF, Steyn M. Absence of percutaneous absorption of aflatoxin. Toxicol Appl Pharmacol. 1973; 24: 162–4.
- Ungar H, Joffe AZ. Acute liver lesions resulting from percuta-neous absorption of aflatoxins. Pharmacol Microbiol. 1969; 33: 65–76.